HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Previous close
$20.47
Day range
$19.93 - $20.64
Year range
$16.10 - $35.72
Market cap
2.52B USD
Avg Volume
2.86M
P/E ratio
67.18
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 458.58M | 132.98% |
Operating expense | 142.68M | 16.96% |
Net income | 215.72M | 475.52% |
Net profit margin | 47.04 | 261.21% |
Earnings per share | 1.67 | 463.04% |
EBITDA | 223.52M | 577.38% |
Effective tax rate | 0.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 480.23M | 18.96% |
Total assets | 1.06B | 17.39% |
Total liabilities | 657.56M | -1.08% |
Total equity | 401.17M | — |
Shares outstanding | 126.53M | — |
Price to book | 6.46 | — |
Return on assets | 59.35% | — |
Return on capital | 74.26% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 215.72M | 475.52% |
Cash from operations | 108.47M | 218.13% |
Cash from investing | -148.00K | — |
Cash from financing | 793.00K | -68.80% |
Net change in cash | 109.14M | 196.47% |
Free cash flow | 17.52M | -76.46% |
About
Founded
2009
Headquarters
Website
Employees
708
